期刊文献+

贯叶金丝桃黄酮类成分大鼠在体肠吸收研究 被引量:1

Intestinal Absorption of Hypericum Perforatum Flavonoids in Rats in vivo
原文传递
导出
摘要 目的:考察贯叶金丝桃2个黄酮类成分在大鼠肠道的吸收特性。方法:采用大鼠在体单向肠灌注模型,测定肠灌流液中芦丁和金丝桃苷含量,计算2个黄酮类成分大鼠小肠的吸收参数。结果:贯叶金丝桃2个黄酮类成分在大鼠肠道的有效渗透系数Peff值均较小;贯叶金丝桃总黄酮Ka、Peff值无显著差异(P>0.05);芦丁和金丝桃苷在不同肠段的Ka顺序分别为回肠>十二指肠>空肠≈结肠,十二指肠>空肠>回肠≈结肠。结论:贯叶金丝桃中2个黄酮类成分为被动扩散吸收,各黄酮类成分的吸收各有不同,芦丁和金丝桃苷的最佳吸收部位分别为回肠和十二指肠。 Objective: To investigate rats' intestinal absorption characteristics of two flavonoids from Hypericum perforatum. Methods: With the rat single- pass intestinal perfusion technique,we measured the contents of rutin and hyperin in intestinal fluids by HPLC- DAD and calculated absorption parameters of the flavonoids in rat intestine. Results: In perfusion model,the Peff of all components was low. Ka and Peff had no significant difference of flavonoids from Hypericum perforatum. The Ka sequences of rutin and hyperin in different intestinal segments were ileum duodenum jejunum≈colon,duodenum jejunum ileum ≈ colon. Conclusion: The absorption of two flavonoids from Hypericum perforatume may be the passive diffusion transport. The absorption rates of each flavonoids are significantly different. The best parts of intestine to absorb rutin and hyperin are ileum and jejunum.
出处 《中华中医药学刊》 CAS 北大核心 2015年第3期519-521,共3页 Chinese Archives of Traditional Chinese Medicine
基金 国家重大新药创制科技重大专项项目(2009ZX09102-142) 山东省科技攻关计划项目(2012GGB14018)
关键词 贯叶金丝桃 芦丁 金丝桃苷 在体单向肠灌流模型 肠吸收 Hypericum perforatume rutin hyperin single-pass perfusion model in vivo intestinal absorption
  • 相关文献

参考文献13

二级参考文献285

共引文献287

同被引文献17

  • 1肖桂青,卢向阳,田云,易克,莫瑾,谭洁.荷叶生物碱药理作用的研究进展[J].湖南农业科学,2006(2):80-81. 被引量:8
  • 2赵骏,王强.荷叶抗氧化活性部位的研究[J].中药材,2006,29(8):827-829. 被引量:22
  • 3Amidon G I,, Lenneruas H, Shah V P, et al. A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability [ J ]. Pharm Res, 1995,12 ( 3 ) :413.
  • 4FDA. Guidance for industry: "Waiver of in invo bio-equivalence studies for immediate release solid oral dosage forms containingcertain active moieties/active ingredients based on a Biopharma- ceutics Classification System" [ EB/OL ]. [ 2015-05 ]. http : // www. fda. gov /Drugs /Guidance Compliance Regulatory Infor- mation/Guidances/default, htm.
  • 5EMA. Note for guidance on the investigation of bioavailability and bioequivalence CPMP/EWP/QWP/1401/98 Revl, Appen- dix Ⅲ [ S]. 2010.
  • 6WHO Expert Committee on Specifications for Pharmaceutical Prepa- rations : WHO Technical Report Series 937 [ EB/OL ], [ 2006-05 ]. http ://whqlibdoc. who. int/trs/WHO TRS 937 eng. pdf.
  • 7You J S, Yun J L, Kim K S, et al. Ethanol extract of lotus (Ne- lumbo nucifera) root exhibits an anti-adipogenic effect in human pre-adipocytes and anti-obesity and anti-oxidant effects in rats fed a high-fat diet[J]. Nutr Res,2014, 34(3) :258.
  • 8Wilson T H, Wiseman G. The use of sacs of everted small intes- tine for the study of the transference of substances from the muco- sal to the serosal surface[ J ]. J Physiol, 1954,123 ( 1 ) : 116.
  • 9赖珺,廖正根,梁新丽,赵国巍.吸收促进剂对葛根素肠吸收的研究[J].江西中医学院学报,2009,21(4):30-32. 被引量:9
  • 10王亚之,欧喜笑,郑颖.外排转运体和代谢酶与黄酮的相互作用及其对黄酮肠吸收影响的研究进展[J].中草药,2009,40(10):1659-1663. 被引量:11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部